289.7 is a legacy non-billable code used to specify a medical diagnosis of methemoglobinemia. This code was replaced on September 30, 2015 by its ICD-10 equivalent. References found for the code 289.7 in the Index of Diseases and Injuries: NADH DPNH methemoglobin reductase congenital 289.7 NADH diaphorase or reductase congenital 289.7
Methemoglobinemia: pathogenesis, diagnosis, and management The diagnosis of methemoglobinemia should be considered in patients presenting with cyanosis and hypoxia. A variety of frequently used medications are capable of inducing methemoglobinemia, with dapsone and benzocaine being common culprits.
A variety of frequently used medications are capable of inducing methemoglobinemia, with dapsone and benzocaine being common culprits. Unique features, such as a saturation gap and chocolate-brown-colored blood, can raise suspicion for methemoglobinemia.
289.7 is a legacy non-billable code used to specify a medical diagnosis of methemoglobinemia. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
References found for the code 289.7 in the Index of Diseases and Injuries:
Your blood is living tissue made up of liquid and solids. The liquid part, called plasma, is made of water, salts and protein. Over half of your blood is plasma. The solid part of your blood contains red blood cells, white blood cells and platelets.
General Equivalence Map Definitions The ICD-9 and ICD-10 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
Methemoglobinemia may be due to a defect in the enzyme nadh methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin m (an autosomal dominant trait). (Dorland, 27th ed) Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
An inherited or acquired condition characterized by abnormally increased levels of methemoglobin in the blood. Signs and symptoms include cyanosis, dyspnea, headache, fatigue, mental status changes, and loss of consciousness. The presence of methemoglobin in the blood, resulting in cyanosis.
Methemoglobinemia. Clinical Information. A condition in which a higher-than-normal amount of methemoglobin is found in the blood. Methemoglobin is a form of hemoglobin that cannot carry oxygen. In methemoglobinemia, tissues cannot get enough oxygen.
Symptoms may include headache, dizziness, fatigue, shortness of breath, nausea, vomiting, rapid heartbeat, loss of muscle coordination, and blue-colored skin. Methemoglobinemia can be caused by injury or being exposed to certain drugs, chemicals, or foods. It can also be an inherited condition.
A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier.
Methemoglobinemia (or methaemoglobinaemia) is a disorder characterized by the presence of a higher than normal level of methemoglobin (metHb, i.e., ferric [Fe3+] rather than ferrous [Fe2+] haemoglobin) in the blood. Methemoglobin is a form of hemoglobin that contains ferric [Fe3+] iron and has a decreased ability to bind oxygen.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code D74. Click on any term below to browse the alphabetical index.
Clinical Information. A condition in which a higher-than-normal amount of methemoglobin is found in the blood. Methemoglobin is a form of hemoglobin that cannot carry oxygen. In methemoglobinemia, tissues cannot get enough oxygen. Symptoms may include headache, dizziness, fatigue, shortness of breath, nausea, vomiting, rapid heartbeat, ...
The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier.
neoplasms ( C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified ( R00 - R94) Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism. Clinical Information. A condition in which a higher-than-normal amount of methemoglobin is found in the blood.
Symptoms may include headache, dizziness, fatigue, shortness of breath, nausea, vomiting, rapid heartbeat, loss of muscle coordination, and blue-colored skin. Methemoglobinemia can be caused by injury or being exposed to certain drugs, chemicals, or foods. It can also be an inherited condition.
Methemoglobinemia: pathogenesis, diagnosis, and management. The diagnosis of methemoglobinemia should be considered in patients presenting with cyanosis and hypoxia. A variety of frequently used medications are capable of inducing methemoglobinemia, with dapsone and benzocaine being common culprits. Unique features, such as a saturation gap and ...
The diagnosis of methemoglobinemia should be considered in patients presenting with cyanosis and hypoxia. A variety of frequently used medications are capable of inducing methemoglobinemia, with dapsone and benzocaine being common culprits. Unique features, such as a saturation gap and chocolate-brown-colored blood, ...